Cibisatamab drug page Clinical trials

Trials with Cibisatamab

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
0Recruiting
7Countries
101Planned patients

Showing 1–2 of 2

Study To Evaluate Safety, Pharmacokinetics, Pharmacodynamics, And Preliminary Anti-Tumor Activity Of RO7122290 In Combination With Cibisatamab With Obinutuzumab Pre-Treatment
Finished Phase 1 54 patients NCT04826003

This is an open-label, multicenter, Phase Ib study to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) in the weekly (QW) and/or every 3 weeks (Q3W) regimens, safety, tolerability, PK, immunogenicity, P…

Denmark, Netherlands, South Korea, Spain and 1 more Jul 2021 – Nov 2024 Interventional
Combined with: ObinutuzumabRO7122290
A Phase Ib Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Cibisatamab in Combination With Atezolizumab After Pretreatment With Obinutuzumab in Participants With Previously Treated Metastatic Colorectal Adenocarcinoma
Finished Phase 1 47 patients NCT03866239

CO40939 is a Phase Ib, open-label, multicenter, single-arm study designed to evaluate the safety, efficacy, pharmacokinetics, and immunogenicity of cibisatamab in combination with atezolizumab administered after pretreatment with obinutuzu…

United States, Denmark, France, Spain May 2019 – Mar 2024 Interventional